What type of study is this?

This is a Literature Review study.

September 19, 2025ChemistrySelect

Progress in the Development of PROTAC Degraders of FLT3

View Full Paper

Ask AI

Bookmark

Authors

This review highlights the development of PROTAC degraders targeting FLT3 in acute myeloid leukemia, suggesting enhanced therapeutic strategies.

Targeting flt3 with PROTAC degraders improves the suppression of flt3 signaling compared to traditional kinase inhibitors.
Recent advancements in PROTAC technology show promise in overcoming drug resistance associated with flt3-related therapies.
The review offers a comprehensive analysis of various PROTAC degraders developed for flt3-positive acute myeloid leukemia.
Fluorescent-based assays were vital in assessing the efficacy of PROTAC degraders on flt3 in clinical contexts.

Fan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review highlights the development of PROTAC degraders targeting FLT3 in acute myeloid leukemia, suggesting enhanced therapeutic strategies.